Is it appropriate to replace my bedtime 0.5 mg clonazepam dose with 1 mg lorazepam (Ativan) while continuing my morning 0.75 mg and midday 0.5 mg clonazepam regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching Bedtime Clonazepam to Lorazepam: Not Recommended

I do not recommend replacing your bedtime 0.5 mg clonazepam with 1 mg lorazepam while maintaining your daytime clonazepam regimen. This mixed benzodiazepine approach creates unnecessary complexity and increases risks without clear benefit.

Key Pharmacologic Concerns

Half-Life Mismatch Creates Problems

Clonazepam has a 30-40 hour elimination half-life 1, providing steady-state coverage throughout the day and night. Lorazepam has a much shorter duration of action 2. Mixing these creates:

  • Uneven benzodiazepine blood levels throughout the 24-hour period
  • Risk of interdose withdrawal symptoms during the day when lorazepam wears off but clonazepam levels fluctuate
  • Complicated tapering if discontinuation becomes necessary
  • Increased confusion about which medication is causing side effects

Dose Equivalency Is Imprecise

The proposed 1 mg lorazepam for 0.5 mg clonazepam represents approximately a 2:1 ratio, but benzodiazepine equivalency is not an exact science. Individual response varies significantly, and you're already on a complex three-times-daily clonazepam regimen totaling 1.75 mg daily.

Clinical Evidence Against Mixed Regimens

Guidelines consistently recommend lorazepam 0.5-1 mg at bedtime for insomnia 3, 2, but this is for monotherapy—not as an add-on to existing long-acting benzodiazepines. The 2008 insomnia guideline 2 notes that "benzodiazepines not specifically approved for insomnia (e.g., lorazepam, clonazepam) might also be considered if the duration of action is appropriate," but emphasizes choosing one agent based on the clinical presentation.

Withdrawal and Rebound Risks

Research demonstrates that lorazepam causes marked rebound insomnia on the third night after discontinuation 4, with withdrawal sleep disturbance "several times the peak degree of sleep improvement." Clonazepam shows similar but delayed rebound effects 5. Mixing these medications means you face:

  • Potential rebound from the short-acting lorazepam between doses
  • Overlapping withdrawal phenomena if either medication is adjusted
  • Immediate relapse risk if clonazepam is missed, as documented in RBD studies 1

What You Should Do Instead

Option 1: Optimize Your Current Clonazepam Regimen (Preferred)

If bedtime sedation is inadequate:

  • Redistribute your total daily clonazepam dose to weight more toward evening (e.g., 0.5 mg morning, 0.25 mg midday, 1 mg bedtime)
  • This maintains the advantage of a single long-acting agent
  • Avoids polypharmacy complications
  • The FDA label 6 supports flexible dosing schedules, noting "the largest dose should be given before retiring"

Option 2: Complete Switch to Lorazepam (If Truly Necessary)

If there's a compelling reason to use lorazepam:

  • Taper off clonazepam completely first (decrease by 0.125 mg every 3 days per panic disorder protocols 6)
  • Then initiate lorazepam monotherapy at 0.5-1 mg at bedtime 3, 2
  • Do not run both medications simultaneously

Option 3: Address the Underlying Problem

Your total daily benzodiazepine dose (1.75 mg clonazepam) is substantial. Consider:

  • Why is bedtime coverage inadequate? Sleep hygiene issues, untreated sleep apnea, or tolerance development?
  • Clonazepam at 0.5-1.0 mg can worsen sleep apnea 1—has this been evaluated?
  • 58% of patients on clonazepam experience moderate-to-severe side effects including morning sedation, confusion, and memory dysfunction 1

Critical Safety Warnings

Falls and Cognitive Impairment

You're on a high total benzodiazepine load. Adding lorazepam increases risk of:

  • Confusion and falls (documented with clonazepam ≥2 mg, potential for subdural hematoma 1)
  • Morning sedation and motor incoordination 1
  • Memory impairment 4—reported even with 2 mg lorazepam

Drug Interactions

The lorazepam label 7 warns about additive CNS depression with other benzodiazepines. Your mixed regimen would create:

  • Enhanced sedation risk
  • Unpredictable respiratory depression, especially if you have sleep apnea
  • Complicated management if you're on other CNS depressants

Bottom Line Algorithm

If inadequate nighttime sedation:

  1. First: Redistribute existing clonazepam to favor bedtime dosing
  2. Second: Evaluate for sleep disorders (apnea, restless legs) or medication tolerance
  3. Third: Consider complete switch to single-agent therapy only if redistribution fails
  4. Never mix short- and long-acting benzodiazepines in the same regimen

The proposed mixed regimen creates more problems than it solves. Work with your prescriber to optimize your current medication rather than adding complexity.

References

Guideline

best practice guide for the treatment of rem sleep behavior disorder (rbd).

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

palliative care version 1.2016.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Clonazepam: sleep laboratory study of efficacy and withdrawal.

Journal of clinical psychopharmacology, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.